NewsBite

Biotech

Advertisement
Scientist Hugh Goold has completed the final stage of an international effort to create a synthetic yeast genome.

Hugh once delivered cheese to the Queen. Now he’s built the key to synthetic life

The first-ever synthetic multicellular organism is ready to come to life after a Sydney breakthrough 10 years in the making.

  • Angus Dalton

Latest

CSL has seen lower vaccination rates in the US, which hit sales of its flu shots.

Falling vaccination rates in Trump’s America hit Australian giant

CSL’s profits have taken a hit from Americans’ reluctance to get vaccinated, sending its shares downward.

  • David Swan
This week’s Bulls N’ Bears ASX Runner of the Week is… Bio-Gene Technology.

ASX Runners of the Week: Bio-Gene, Alterity, Aston & Canterbury

This week’s ASX Bulls N’ Bears Runner of the Week is… Bio-Gene Technology. The company’s shares leapt after revealing it scored a slice of two US defence grants.

  • Craig Nolan
Boston is an exception in the biotech world. While other centres struggle, the city’s biotechs are performing strongly.

Riding the scariest rollercoaster on the ASX

If you thought crypto investors need to have strong stomachs, spare a thought for the investors who try their luck in the biotech sector.

  • William Bennett
This week’s Bulls N’ Bears ASX Runner of the Week is … Hydration Pharmaceuticals.

Hydration rehydrates share price with non-US asset sale

This week’s Bulls N’ Bears Runner of the Week is … Hydration Pharmaceuticals. The company sold its non-US assets for a sum five times its market capitalisation.

  • Craig Nolan
Novo Nordisk’s diabetes and weight-loss drugs, Ozempic and Wegovy, have soared to celebrity status.

It introduced Ozempic to the world. Now it must remake itself

Danish drugmaker Novo Nordisk has eclipsed French luxury group LVMH to become Europe’s most valuable company – thanks to demand for diabetes and weight-loss drugs.

  • Eshe Nelson
Advertisement

The artificial heart set to transform medicine – and the Aussie who invented it

Biomedical engineer Daniel Timms lost his father to heart disease, but their kitchen-top tests helped him hone a radical idea.

  • Amanda Hooton

The April 20 Edition

The Aus-designed artificial heart set to revolutionise medicine | Preppers go mainstream | A sperm donor’s message to his progeny

Australian research has led to a number of highly-significant medical innovations.

Our track record in medical innovation can only be maintained with funding support

Australian researchers are responsible for a series of globally significant medical inventions and innovations.

  • The Herald's View
Jason Kovacic, executive director of the Victor Chang Cardiac Research Institute, said indirect funding was critical to research.

Future of medical research in doubt as question mark lingers over $45 million funding

The future of a government funding program which has assisted teams developing artificial hearts and turning spider venom into drug therapies is in doubt.

  • Mary Ward

Original URL: https://www.smh.com.au/topic/biotechnology-5v0